Products Categories
    Product Certification&
    Enterprise Certification

  • Ms.Yolanda
    Tel: 0086-10-64430626

  • Mobile:0086-15201201811
  • Tel:0086-10-64430626
  • Fax:0086-10-64439981
  • Province/state:Beijing
  • City:Beijing
  • Street:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
  • MaxCard:
Home > Products >  Apixaban

Apixaban CAS NO.503612-47-3

  • Min.Order: 100 Kilogram
  • Payment Terms:
  • Product Details

Keywords

  • Apixaban
  • buy Apixaba
  • 503612-47-3

Quick Details

  • ProName: Apixaban
  • CasNo: 503612-47-3
  • Appearance: white powder
  • PackAge: as per your requirement
  • ProductionCapacity: 1-50 Metric Ton/Day
  • Purity: 98%min
  • LimitNum: 100 Kilogram

Superiority

Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation.
Apixaban is a factor Xa inhibitor (anticoagulant) indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. A systematic review of new anticoagulants states the treatment benefits of apixaban and other new anticoagulants compared with warfarin are small and vary depending on the control achieved by warfarin treatment. Patients already taking warfarin with excellent international normalized ratio (INR) control may have little to gain by switching to new oral anticoagulants in atrial fibrillation.

Details

Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation.
Apixaban is a factor Xa inhibitor (anticoagulant) indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. A systematic review of new anticoagulants states the treatment benefits of apixaban and other new anticoagulants compared with warfarin are small and vary depending on the control achieved by warfarin treatment. Patients already taking warfarin with excellent international normalized ratio (INR) control may have little to gain by switching to new oral anticoagulants in atrial fibrillation.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog